Safety and effectiveness of long-term treatment with lurasidone in older adults with bipolar depression: Post-hoc analysis of a 6 month, open-label study
The American Journal of Geriatric Psychiatry Oct 15, 2017
Forester BP, et al. - The safety and effectiveness of 6 months of treatment with lurasidone in older adults with a diagnosis of bipolar I depression were assessed. Outcomes of these post-hoc analyses found that in older adults, up to 7.5 months of lurasidone treatment for bipolar depression was correlated with minimal effects on weight and metabolic parameters, with low rates of switching to hypomania or mania, and was well-tolerated. In this age group, the antidepressant effectiveness of lurasidone was maintained over the 6-month treatment period.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries